Bruce Kovner, Director, 10% Owner at SYNTA PHARMACEUTICALS CORP (SNTA), bought 2,000,000 shares at $4.31 ($9.3M) on 2013-06-06, disclosed to the SEC on 2013-06-06.
Open-market purchase of $9.3M SNTA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.99 | 505,100 | $2.5M | 27.2% |
| 2 | $4.71 | 756,000 | $3.6M | 38.4% |
| 3 | $4.31 | 738,900 | $3.2M | 34.4% |
| Total | $4.63 avg | 2,000,000 | $9.3M | 100% |
| Filing → |
| SBBP | BUY | 2018-12-21 | $1.3M | — | Filing → |
| SBBP | BUY | 2018-08-09 | $3.6M | — | Filing → |
| SBBP | BUY | 2018-07-27 | $2.6M | — | Filing → |